In this video interview, Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at the Northwestern ...

In this video interview, Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at the Northwestern ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product ...

NEMLUVIO is the first authorized monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling ...

J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action ...

In spite of its commonality, there are still plenty of unknowns around atopic dermatitis, including the actual cause of the skin condition. Perhaps that’s why there are so many myths surrounding it.

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar. These ...

Collaborating institutions in Taiwan report higher risks of atopic disease among children conceived via assisted reproductive ...

There is no cure for atopic dermatitis, but there are treatments that can ease symptoms like itch and inflammation and reduce flare-ups. Medications, moisturizers, and at-home skin-care routines are ...

Atopic dermatitis (AD) is a chronic skin condition that causes dry skin and rashes. Effective management is crucial for a higher quality of life and better sleep. Treatment options for AD range from ...

Continued strong growth of ZORYVE® (roflumilast) in 2026 with full-year net product sales guidance of $455–$470 millionAdvancement of ZORYVE ...

Children conceived via assisted reproductive technology (ART) have a higher risk for developing atopic disease.